1.Evaluating the results of therapeutic procedures of rectal cancer
Journal of Preventive Medicine 2001;11(4):30-36
190 cases of rectal cancers were treated by operation from 1986-1993 at the Cho Ray Hospital. Analyzing some characteristics: pathology, classification of dukes, choosing the therapeutic method, evaluating, post-operative observation. The mortality rate, the operative accidents, the post-operative complications, the recurrence, the 5 years post -surgical prognosis: radical operations were still little. The choice of surgical procedure depended on location and the stage of carcinoma as the patients condition. Sphincter preservation will be performed more if the disease is diagnosed early
Rectal Neoplasms
;
Methods
2.Hartmann surgical treatment for rectal cancer
Journal of Practical Medicine 2000;383(6):11-14
During 8 years from 1986-1993, 35 rectal cancer cases were treated by Hartmann procedure at Chî RÉy hospital' s General surgery Department. This procedure was performed for the middle-third of rectum (85.7%) and unmetastasis stage. Results: the operation related mortality rate was: 2.9%. Severe bleeding happened in 3 cases during operation: 8.5%. The most commonly occurred post-operative complication was infection and the most severity was pelvic abscess. The surgery of 24/34 patients, the prognosis was favorable: The 5 years survival rate was 83.3%, the recurrent rate was 11.7% and post-operative metastasis was 5.7%.
Rectal Neoplasms
;
Therapeutics
3.Miles operation’s results in treatment of the rectal cancer
Journal of Practical Medicine 2002;435(11):25-27
During 8 years from 1986- 1993, we applied the Miles, operation to treat 44 patients who had got rectal cancer at Chî RÉy Hospital, General Surgery Department. This procedure was performed on the low rectal cancer: 1/3 low rectum (77,3%), 1/3 middle rectum (22,7%). Results: - The bleeding happened during operation: 6,8%. - The vaginal perforation:3,2%. - The most post- operative complication was: perineum infection(47,7%). - The mortality rate was: 4,6% and the recurrent rate was:13,6%. The 5 year survival according to Dukes’ classification was: A(100%), B (77,8%), C(25%).
Rectal Neoplasms
;
Therapeutics